Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer

BACKGROUND: A large number of patients with stage II/III colorectal cancer (CRC) have a high recurrence rate after radical resection. We aimed to develop a novel tool to stratify patients with different recurrence-risk for optimizing decision-making in post-operative surveillance and therapeutic reg...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Cell Int
Glavni autori: Liu, Zaoqu, Lu, Taoyuan, Li, Jing, Wang, Libo, Xu, Kaihao, Dang, Qin, Guo, Chunguang, Liu, Long, Jiao, Dechao, Sun, Zhenqiang, Han, Xinwei
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Primary Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265123/
https://ncbi.nlm.nih.gov/pubmed/34233675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-02070-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items